查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863376

影像CRO市场：按提供者类型、服务类型、影像模式、临床试验阶段、适应症和最终用户划分－2025-2032年全球预测

Imaging CRO Market by Provider Types, Service Type, Imaging Modality, Phase of Clinical Trials, Indication, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，成像 CRO 市场将成长至 33.8 亿美元，复合年增长率为 6.17%。

关键市场统计数据
基准年 2024 20.9亿美元
预计年份：2025年 22.1亿美元
预测年份 2032 33.8亿美元
复合年增长率 (%) 6.17%

建构现代化的影像临床研究生态系统，使营运能力与科学和监管要求一致，从而确保试验成功。

诊断影像临床研究领域需要严格且独立地整合营运能力、科学标准和监管准备，以支援生命科学和医疗设备企业的决策者。本执行摘要介绍了影响外包诊断影像服务的核心主题，重点阐述了卓越营运、专业技术以及整合资料管理如何共同影响研究设计和执行。以下分析提取了关键产业趋势、细分资讯、区域差异以及建议的策略行动，供经营团队参考，以优化供应商选择、资源分配和研究监管。

本报告始终强调实际应用价值而非抽象趋势，确保研究结果能应用于实际专案规划。引言部分阐述了关键驱动因素——包括不断推进的定量影像终点、对互操作系统的需求以及不断变化的监管要求——这些因素共同促使我们采取更具战略性的方式与影像CRO合作。最终，读者将获得一个平衡的观点，该视角将技术进步与营运限制相结合，为后续章节奠定了基础。后续章节将深入探讨转型变革、关税影响、市场区隔、区域性考量以及公司层面的行动。透过预先设定这些背景讯息，本摘要有助于读者理解，并能快速将研究结果转化为采购、研究设计和伙伴关係决策。

影像技术、资料整合和监管要求的进步如何融合，从而重新定义供应商的能力和试验运作？

诊断影像临床研究领域正经历变革性的转变，这主要得益于影像技术的进步、资料实践的改进以及监管力度的加强，这些因素共同重塑了医疗服务提供者的角色和服务模式。供应商正从单一模态服务转向整合影像撷取监管、集中阅片和纵向资料协调的平台，以支援复杂的终点指标和分散的研究要素。同时，定量影像生物标记的日益普及推动了对标准化采集通讯协定、跨供应商校准方法以及与供应商无关的分析工具链的投资。

这些变化要求企划团队加强临床运作、影像核心实验室和生物统计部门之间的协作，以确保影像衍生终点的稳健性和可重复性。此外，业界正日益转向云端基础的影像管理和安全的联邦学习方法，以在保护资料隐私的同时实现多中心模型开发。同时，关于演算法解读和数位生物标记检验的监管对话也在不断发展，这使得透明的检验流程和审核的资料管理变得愈发重要。这些协同效应正迫使医疗服务提供者提升其在资料整合、品质保证和监管支援方面的能力，并促使申办方优先选择能够展现系统严谨性和适应性服务模式的供应商。

2025年新关税措施的营运影响：诊断影像服务的采购本地化、成本分配策略和合约风险缓解

2025年实施的新关税的累积影响进一步增加了依赖跨境设备采购和跨国供应链的诊断影像服务供应商的营运复杂性。关税导致诊断影像硬体、专用耗材和某些辅助技术的到岸成本增加，迫使服务提供者重新评估其筹资策略、优化库存计划，并重新考虑专科中心模式和分散式服务交付的经济效益。

因此，影像设备供应商正在协商长期供应协议，以加速关键供应链的本地化，并稳定价格和服务连续性。这项转变进一步强化了利用远端影像阅片和集中处理来减少研究中心之间重复部署本地设备的必要性。此外，申办方和供应商在选择影像设备以及在通讯协定中明确扫描仪要求时，越来越重视研究开展的总落地成本，并优先考虑能够降低跨境旅行及相关海关手续复杂性的解决方案。

同时，不断变化的关税环境促使合约条款中关于成本转嫁、风险分配以及应对未来贸易政策变化的紧急时应对计画被正式写入合约。作为一项临时措施，一些服务供应商已开始提供区域服务包和区域仓储服务，以在维持服务水准的同时，吸收部分采购成本的波动。这些调整表明，贸易政策趋势正在转化为以影像为重点的临床调查计画在供应商选择、营运规划和合约管治方面的实际变化。

一种多维细分框架，揭示了提供者类型、服务线、模式、试验阶段、适应症和最终用户如何影响诊断影像检查决策。

了解市场细分，例如供应商类型、服务线、影像模式、临床试验阶段、适应症和最终用户，对于就供应商选择和专案设计做出明智的决策至关重要。在供应商类型方面，全方位服务的合约研究组织 (CRO)、专业影像核心实验室和专注于影像的 CRO 之间的区别，决定了申办方获得的是端到端的管理解决方案，还是集中阅片和影像管治方面的特定功能。在服务类型方面，临床影像服务、资料管理和整合、计划管理和试验支援以及法规和合规服务之间的区别，决定了影像活动是融入到更广泛的试验营运中，还是作为一项独立的技术服务进行外包。

此外，影像方式（CT、MRI、PET 和超音波）和亚专科（例如多切面CT 与螺旋 CT、弥散张量磁振造影与功能性磁振造影、3D/4D超音波与多普勒超音波）的差异，对研究中心的选择标准、阅片者的专业水平和采集通讯协定的设计均有显着影响。根据临床试验阶段，I 期、II 期和 III 期研究需要不同的终点检验、影像审查频率以及所需的监管文件范围。根据适应症，临床重点关注心臟病学、感染疾病、肌肉骨骼系统疾病、神经病学、肿瘤学和眼科学，这些因素决定了成像方式的选择和阅片者的专业水平，以匹配疾病特异性的影像生物标记。最后，在基于最终用户的分类中，生物技术公司、医疗设备製造商、製药公司以及科研和学术机构的需求会影响采购行为、首选合约模式以及对科研合作的期望。总的来说，这些分类观点提供了一个多维框架，以支援有针对性的供应商评估、营运设计选择和资源分配决策。

区域营运实务和适应策略（美洲、欧洲、中东和非洲、亚太地区）会影响诊断影像研究的效能和资料品质。

区域趋势对影像临床研究服务的提供、合约签订和监管方式有显着影响。认识到这些差异对于全球专案规划至关重要。在美洲，主要学术研究机构的集中以及成熟的专业影像供应商网络，使得开展需要严格影像标准和可扩展的集中阅片流程的复杂大规模试验成为可能。该地区的转型因素包括对互通性的重视，以及支付方和监管机构就影像衍生替代终点展开的积极讨论，这些都将影响通讯协定设计和证据生成策略。

在欧洲、中东和非洲地区，报销架构、监管协调工作以及临床基础设施的差异，造就了更多元化的服务环境。在该地区开展业务的申办方必须制定差异化的研究中心选择策略，并做好准备，以适应各种扫描器型号、语言要求和当地资料保护制度。同时，亚太地区正处于快速发展阶段，对影像硬体和学术临床研究能力的投资正在加速成长，但区域物流、研究者培训和影像校准物流等营运挑战仍然是关注的焦点。过渡性方法，例如区域影像处理中心、本地化培训计画和适应性合同，有助于弥合能力差距，并在跨司法管辖区的研究中保持数据品质的一致性。这种地理观点对于设计符合全球计画目标、切合当地实际情况的影像策略至关重要。

供应商策略、技术投资和伙伴关係模式如何塑造诊断影像服务的竞争差异化和赞助商参与度

一些成熟的医疗机构和众多专业实验室正携手合作，共同塑造诊断影像服务的竞争格局。他们的行动中涌现出几个通用的主题，这些主题对申办者的参与度产生了影响。大型医疗机构透过投资可扩展的影像管理平台、检验的读片演算法和整合的品管系统来脱颖而出，从而确保各站点效能的一致性。同时，专注于特定领域的诊断影像核心实验室则凭藉其在影像模式和治疗领域的专业知识深度展开竞争，提供高度客製化的通讯协定开发和读片培训，以应对复杂的终点指标。

除了这些企业级策略之外，企业越来越重视透过伙伴关係和联盟来拓展技术能力，例如人工智慧驱动的影像判读、云端原生资料整合以及用于多中心研究的联合分析。此外，企业正在将监管咨询和证据产生规划纳入其服务组合，从而减少申办者工作流程中的摩擦。在营运方面，那些强调透明检验流程、完善审核追踪和客户可存取仪錶板的企业，越来越受到既追求科学严谨性又注重营运透明度的申办方的青睐。最后，灵活的合约模式和提供本地支援的能力也是重要的竞争优势，有助于确保跨国试验能够采用一致的影像标准和可预测的时间表。

经营团队可采取实际行动，协调供应商能力、资料管治和合约签订方式，以确保强大的成像终端和营运弹性。

产业领导者应采取一系列切实可行的措施，以维持专案发展势头，管控营运风险，并从影像衍生终点创造科学价值。首先，供应商选择标准应与已证实的特定成像方式专业知识和标准化的采集通讯协定相匹配，以确保不同站点和阅片者之间的一致性。其次，要求演算法或半自动阅片工具提供透明的检验文檔，并遵守审核的资料管理流程，以促进与监管机构的沟通。第三，筹资策略应考虑与供应链风险和关税相关的成本波动，优先选择具有成熟在地采购或区域仓储能力的供应商。

此外，申办方应在通讯协定设计初期就引入跨职能管治，让影像专家、生物统计学家和临床运作负责人参与其中，以避免返工和终点定义模糊。他们还应优先选择能够提供整合资料管理功能和互通性的供应商，以减少人工核对并加快资料锁定。最后，他们应考虑平衡风险和灵活性的合约结构，例如与交付成果挂钩的里程碑付款，并协商明确的服务等级协定 (SLA) 和紧急时应对计画。全面实施这些措施将有助于提高试验执行的稳健性，增强对影像终点的信心，并促进与监管机构的顺畅沟通。

本报告的证据基础是透过混合方法建构的，该方法整合了专家访谈、通讯协定标准和同行评审文献，以检验操作知识和调查方法的严谨性。

本报告的研究途径结合了与主题专家的结构化面对面对话、与行业相关人员的结构化定性访谈，以及对已发布的监管指南和同行评审文献的严谨二手资料研究，以确保评估的平衡性和检验。主要研究包括与影像科学家、临床营运总监和监管事务专家进行咨询，检验营运场景并识别研究执行中出现的新挑战。这些访谈为贯穿本报告的分析框架的建构提供了讯息，尤其是在模态选择、阅片者检验和资料整合模式方面。

二次研究回顾了目前关于技术标准、成像通讯协定指南和定量成像生物标记的文献，以阐明操作最佳实践和监管要求。数据综合强调多资讯来源三角验证，以提高可靠性并尽可能达成共识。在整个调查方法中，我们始终专注于记录假设、保持对关键资讯来源的可追溯性，并保护关键资讯提供者的隐私。这种混合方法为本报告中提出的策略指导和建议提供了切实可行的实证基础。

将营运重点、监管准备和策略供应商选择连结的整体观点，可确保影像技术为临床专案目标的实现做出贡献。

本执行摘要了依赖外包诊断影像服务的团队在决策过程中需要考虑的关键营运、监管和商业因素。它重点阐述了影像模式的专业化、资料整合能力以及不断变化的监管预期如何改变供应商的选择标准和研究设计方法。分析表明，需要儘早影像终点、标准化采集通讯协定以及针对人工和演算法辅助解读的可靠检验流程达成跨职能共识。

此外，摘要强调了供应链和关税压力对采购和合约签订的实际影响，并提案申办方积极将风险缓解措施纳入其供应商策略。应对区域差异需要针对站点选择和数据协调制定客製化方法。同时，企业层面的趋势表明，与兼具专业知识和透明、扩充性平台的供应商合作具有重要价值。总之，强烈建议申办方将这些发现转化为采购流程、通讯协定製定和管治的具体改进，以确保诊断影像能为证据产生和临床专案的整体成功做出贡献。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩展用于分散式测试工作流程的AI驱动影像分析平台
  • 将先进的数位病理成像服务整合到多机构肿瘤研究中
  • 标准化定量成像生物标记以支持全球监管申报
  • 引入云端基础的影像管理系统，实现多个设施之间的即时协作
  • 自动病灶检测演算法的出现提高了纵向研究的准确性
  • 更多地使用远端影像判读服务来缩短审理週期并提高效率
  • 利用多模态影像终点进行免疫肿瘤学试验的全面评估
  • 引入基于人工智慧的品管检查，以减少人工影像判读错误。
  • 扩展整合成像和数位生物标记解决方案以实现患者分层定制
  • 扩展功能性磁振造影终点，用于在后期临床试验中监测神经退化性疾病

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按提供者类型分類的影像CRO市场

  • 全方位CRO服务
  • 影像核心实验室
  • 成像 CRO

9. 按服务类型分類的成像 CRO 市场

  • 临床影像服务
  • 资料管理与集成
  • 计划管理和测试支持
  • 法规与合规

第十章：以成像方式分類的成像CRO市场

  • 电脑断层扫描（CT）
    • 多切面CT
    • 螺旋CT
  • 磁振造影（MRI）
    • 扩散张量造影
    • 功能性磁振造影
  • 正子断层扫描（PET）
  • 超音波
    • 3D和4D超音波
    • 多普勒超音波

第十一章 依临床试验阶段分類的影像CRO市场

  • 第一阶段
  • 第二阶段
  • 第三阶段

第十二章：按适应症分類的影像CRO市场

  • 心臟病学
  • 感染疾病
  • 肌肉骨骼系统
  • 神经病学
  • 肿瘤学
  • 眼科

第十三章：依最终用户分類的成像CRO市场

  • 生技公司
  • 医疗设备製造商
  • 製药公司
  • 研究和学术机构

第十四章：按地区分類的成像CRO市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 影像CRO市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国影像CRO市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH
    • Biospective Inc.
    • Biotrial
    • Bruker Corporation
    • Celentyx Ltd.
    • Charles River Laboratories, Inc.
    • Clario
    • EPS Corporation
    • GVK Biosciences Private Limited
    • ICON PLC
    • Image Analysis Group
    • Intelerad Medical Systems Incorporated
    • IQVIA Inc.
    • Median Technologies PLC
    • Medidata by Dassault Systemes SE
    • MERIT CRO, Inc.
    • Micron, Inc.
    • Mint Medical Inc.
    • MUSASHI IMAGE JOHO CO.,LTD.
    • Parexel International Corporation
    • Perceptive Informatics LLC
    • Visikol, Inc.
    • WCG Clinical, Inc.
Product Code: MRR-2E76C3E47FC3

The Imaging CRO Market is projected to grow by USD 3.38 billion at a CAGR of 6.17% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.09 billion
Estimated Year [2025] USD 2.21 billion
Forecast Year [2032] USD 3.38 billion
CAGR (%) 6.17%

Framing the contemporary imaging clinical research ecosystem to align operational capabilities with scientific and regulatory demands for trial success

The imaging clinical research landscape demands a rigorous, independent synthesis of operational capabilities, scientific standards, and regulatory alignment to support decision-makers across life sciences and medical device organizations. This executive summary introduces the core themes that shape outsourced imaging services, highlighting how operational excellence, modality specialization, and integrated data management converge to influence trial design and execution. The following analysis distills critical industry movements, segmentation intelligence, regional nuances, and recommended strategic responses that executives can use to refine vendor selection, resource allocation, and trial oversight.

Throughout the report, emphasis is placed on practical implications rather than abstract trends, ensuring that insights can be applied to real-world program planning. The introduction frames key drivers such as rising sophistication in quantitative imaging endpoints, the need for interoperable data systems, and evolving regulatory expectations that together demand a more strategic approach to imaging CRO engagement. Consequently, readers will find a balanced view that connects technological advances with operational constraints, offering a foundation for subsequent sections that detail transformative shifts, tariff impacts, segmentation implications, regional considerations, and company-level behavior. By setting this context up front, the summary aims to accelerate comprehension and support rapid translation of intelligence into procurement, trial design, and partnership decisions.

How converging advances in imaging modalities, data integration, and regulatory expectations are redefining vendor capabilities and trial operations

The imaging clinical research field is experiencing transformative shifts driven by advances in imaging technologies, data practices, and regulatory scrutiny that together are reshaping provider roles and service delivery models. Vendors are moving beyond single-modality service delivery toward integrated platforms that combine image acquisition oversight, centralized reading, and longitudinal data harmonization to support complex endpoints and decentralized trial elements. At the same time, the growing adoption of quantitative imaging biomarkers is prompting investments in standardized acquisition protocols, cross-vendor calibration approaches, and vendor-agnostic analytic toolchains.

As a result of these changes, project teams must now emphasize tighter collaboration between clinical operations, imaging core labs, and biostatistics to ensure image-derived endpoints are robust and reproducible. Furthermore, the industry is seeing enhanced focus on cloud-based image management and secure federated learning approaches to preserve data privacy while enabling multi-site model development. In addition, regulatory dialogues are evolving to address validation of algorithmic reads and digital biomarkers, which increases the importance of transparent validation pathways and audit-ready data curation. These converging forces are encouraging providers to expand capabilities in data integration, quality assurance, and regulatory support, and they are influencing sponsors to prioritize vendors who can demonstrate systemic rigor and adaptive service models.

Operational implications of new 2025 tariff measures driving procurement localization, cost allocation strategies, and contractual risk mitigation in imaging services

The cumulative effect of new tariff measures implemented in 2025 has introduced additional operational complexity for imaging service providers that rely on cross-border equipment procurement and multinational supply chains. Tariff-driven increases in the landed cost of imaging hardware, specialized consumables, and certain ancillary technologies have compelled providers to re-evaluate procurement strategies, optimize inventory planning, and reconsider the economics of center-of-excellence models versus distributed service delivery.

Consequently, imaging providers have accelerated efforts to localize critical supply chains and to negotiate long-term supplier agreements that can stabilize pricing and service continuity. This shift has also intensified the rationale for leveraging remote image reading and centralized processing to mitigate the need for repeated on-site equipment deployments across trial sites. Moreover, sponsors and providers are increasingly assessing the total landed cost of trial execution when selecting imaging modalities or specifying scanner requirements in protocols, prioritizing solutions that reduce cross-border movements and associated customs complexity.

In parallel, the tariff environment has prompted more structured contract language around cost pass-through, risk allocation, and contingency planning to manage potential future trade policy fluctuations. As a transitional measure, some service providers are offering localized service bundles and regional warehouses to maintain service level commitments while absorbing some procurement cost volatility. Together, these adaptations illustrate how trade policy dynamics translate into pragmatic changes in vendor selection, operational planning, and contractual governance across imaging-focused clinical research programs.

A multidimensional segmentation framework revealing how provider types, service lines, modalities, trial phases, indications, and end users shape imaging research decisions

Understanding how the market segments across provider types, service lines, imaging modalities, clinical trial phases, indications, and end users is essential to making informed decisions about vendor selection and program design. Based on provider types, distinctions between full-service contract research organizations, specialized imaging core labs, and imaging-focused CROs determine whether a sponsor will receive an end-to-end managed solution or a targeted competency in centralized reads and imaging governance. Based on service type, differences among clinical imaging services, data management and integration, project management and trial support, and regulatory and compliance offerings shape the extent to which imaging is embedded within broader trial operations or contracted as a discrete technical service.

Further, based on imaging modality, variation across CT, MRI, PET, and ultrasound-and the sub-specializations such as multislice versus spiral CT, diffusion tensor and functional MRI, and 3D/4D versus Doppler ultrasound-creates important implications for site qualification, reader expertise, and acquisition protocol design. Based on phase of clinical trials, requirements in Phase I, Phase II, and Phase III studies differ in terms of endpoint validation, frequency of imaging assessments, and the degree of regulatory documentation required. Based on indication, the clinical focus on cardiology, infectious diseases, musculoskeletal, neurology, oncology, and ophthalmology drives modality selection and reader specialization to align with disease-specific imaging biomarkers. Finally, based on end-user, the needs of biotechnology firms, medical device companies, pharmaceutical companies, and research and academic institutions influence procurement behavior, desired contracting models, and expectations for scientific collaboration. When taken together, these segmentation lenses provide a multidimensional framework that supports targeted vendor evaluation, operational design choices, and resource allocation decisions.

Regional operational realities and adaptive strategies across the Americas, EMEA, and Asia-Pacific that influence imaging trial execution and data quality

Regional dynamics exert a material influence on how imaging clinical research services are delivered, contracted, and regulated, and acknowledging these differences is vital for global program planning. In the Americas, concentrations of leading academic centers and a well-established network of specialized imaging vendors facilitate complex, high-volume trials that demand rigorous imaging standards and scalable centralized reading operations. Transitional factors in the region include an emphasis on interoperability and an active payer and regulatory discourse around imaging-derived surrogate endpoints, which affects protocol design and evidence generation strategies.

Across Europe, the Middle East, and Africa, variability in reimbursement frameworks, regulatory harmonization efforts, and clinical infrastructure leads to a more heterogeneous service landscape. Sponsors operating in this region must plan for differentiated site qualification strategies and be prepared to manage varied scanner models, language requirements, and local data protection regimes. Meanwhile, Asia-Pacific presents a rapidly evolving environment in which investments in imaging hardware and academic clinical research capacity are accelerating, yet operational considerations such as regional standardization, investigator training, and logistics for imaging calibration remain focal points. In each region, transitional approaches-such as regional hubs for image processing, localized training programs, and adaptive contracting-help bridge capability gaps and support consistent data quality across multi-jurisdictional studies. This geographical perspective is essential for designing pragmatic, regionally sensitive imaging strategies that align with global program objectives.

How provider strategies, technology investments, and partnership models are shaping competitive differentiation and sponsor engagement in imaging services

A small number of well-established providers and a broader set of specialized labs collectively define the competitive landscape for imaging services, and company behaviors reveal several consistent themes that affect sponsor engagement. Leading providers are differentiating through investments in scalable image management platforms, validated reading algorithms, and integrated quality management systems that enable consistent cross-site performance. At the same time, niche imaging core labs are competing on depth of modality expertise and therapeutic area specialization, offering highly tailored protocol development and reader training that address complex endpoints.

These company-level strategies are accompanied by an increasing focus on partnerships and alliances that extend technical capabilities into areas such as AI-augmented reads, cloud-native data integration, and federated analytics for multi-site studies. Additionally, firms are broadening service portfolios to include regulatory consulting and evidence generation planning to reduce friction in sponsor workflows. Operationally, companies that emphasize transparent validation processes, robust audit trails, and client-accessible dashboards tend to gain preference among sponsors seeking both scientific rigor and operational transparency. Finally, competitive differentiation is also driven by the ability to deliver flexible contracting models and localized support, which helps enable multinational trials with consistent imaging standards and predictable timelines.

Practical actions for executives to align vendor capabilities, data governance, and contracting approaches to secure robust imaging endpoints and operational resilience

Industry leaders should adopt a set of pragmatic actions to maintain program momentum, manage operational risk, and capture scientific value from imaging-derived endpoints. First, align vendor selection criteria with specific modality expertise and evidence of standardized acquisition protocols to ensure consistency across sites and readers. Second, require transparent validation documentation for any algorithmic or semi-automated reading tools and insist on audit-ready data curation processes that facilitate regulatory interactions. Third, incorporate procurement strategies that account for supply chain risks and tariff-related cost variability by favoring vendors with demonstrable localized sourcing or regional warehousing capabilities.

Additionally, sponsors should embed cross-functional governance that brings imaging specialists, biostatisticians, and clinical operations into early protocol design to avoid rework and endpoint ambiguity. It is also advisable to prioritize providers that offer integrated data management and interoperability features to reduce manual reconciliation and accelerate data lock. Finally, consider contracting modalities that balance risk and flexibility, such as milestone-based payments tied to deliverables, while negotiating clear service-level agreements and contingency plans. Taken together, these actions will support more resilient trial execution, higher confidence in imaging endpoints, and smoother regulatory dialogues.

A mixed-methods evidence base integrating expert interviews, protocol standards, and peer-reviewed literature to validate operational insights and methodological rigor

The research approach underpinning this report combines systematic primary engagement with subject-matter experts, structured qualitative interviews with industry stakeholders, and rigorous secondary analysis of publicly available regulatory guidance and peer-reviewed literature to ensure a balanced and verifiable assessment. Primary engagements included consultations with imaging scientists, clinical operations leads, and regulatory affairs specialists to validate operational scenarios and identify emerging pain points in trial execution. These interviews informed the development of analytic frameworks used throughout the report, particularly with respect to modality selection, reader validation, and data integration patterns.

Secondary research encompassed a review of technical standards, imaging protocol guidelines, and recent publications on quantitative imaging biomarkers to contextualize operational best practices and regulatory expectations. Data synthesis emphasized triangulation across sources to enhance reliability and to surface consensus where possible. Throughout the methodology, careful attention was paid to documenting assumptions, maintaining traceability of insights to source inputs, and preserving confidentiality of primary contributors. Together, this mixed-methods approach yields a pragmatic, evidence-based foundation for the strategic guidance and recommendations offered in the report.

Summative perspective linking operational priorities, regulatory readiness, and strategic vendor choices to ensure imaging contributes reliably to clinical program objectives

This executive summary synthesizes key operational, regulatory, and commercial considerations that will inform decision-making for teams that rely on outsourced imaging services. It highlights how modality specialization, data integration capabilities, and evolving regulatory expectations are changing provider selection criteria and trial planning practices. The analysis reinforces the need for early, cross-functional alignment on imaging endpoints, standardized acquisition protocols, and robust validation pathways for both human reads and algorithm-assisted interpretations.

Moreover, the summary underscores the practical implications of supply chain and tariff pressures on procurement and contracting, suggesting that sponsors proactively integrate risk mitigation measures into their vendor strategies. Regional differences require tailored approaches to site qualification and data harmonization, while company-level behaviors point to the value of partnering with providers who combine domain expertise with transparent, scalable platforms. In closing, the conclusion urges sponsors to translate the insights into concrete changes in procurement, protocol development, and governance so that imaging contributes reliably to evidence generation and to the overall success of clinical programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of AI-driven imaging analysis platforms for decentralized trial workflows
  • 5.2. Integration of advanced digital pathology imaging services into multi center oncology studies
  • 5.3. Standardization of quantitative imaging biomarkers to support regulatory submissions globally
  • 5.4. Adoption of cloud based image management systems for real time collaboration across sites
  • 5.5. Emergence of automated lesion detection algorithms for enhanced accuracy in longitudinal studies
  • 5.6. Rising utilization of remote image reading services to accelerate trial timelines and efficiency
  • 5.7. Leveraging multi modal imaging endpoints for comprehensive assessment in immuno oncology trials
  • 5.8. Implementation of AI based quality control checks to reduce manual image interpretation errors
  • 5.9. Growth of integrated imaging and digital biomarker solutions for personalized patient stratification
  • 5.10. Expansion of functional MRI endpoints for neurodegenerative disease monitoring in late stage trials

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Imaging CRO Market, by Provider Types

  • 8.1. Full-Service CROs
  • 8.2. Imaging Core Labs
  • 8.3. Imaging CROs

9. Imaging CRO Market, by Service Type

  • 9.1. Clinical Imaging Services
  • 9.2. Data Management & Integration
  • 9.3. Project Management & Trial Support
  • 9.4. Regulatory & Compliance

10. Imaging CRO Market, by Imaging Modality

  • 10.1. Computer Tomography (CT) Scan
    • 10.1.1. Multislice CT
    • 10.1.2. Spiral CT
  • 10.2. Magnetic Resonance Imaging (MRI)
    • 10.2.1. Diffusion Tensor Imaging
    • 10.2.2. Functional MRI
  • 10.3. Positron Emission Tomography (PET)
  • 10.4. Ultrasound
    • 10.4.1. 3D & 4D Ultrasound
    • 10.4.2. Doppler Ultrasound

11. Imaging CRO Market, by Phase of Clinical Trials

  • 11.1. Phase I
  • 11.2. Phase II
  • 11.3. Phase III

12. Imaging CRO Market, by Indication

  • 12.1. Cardiology
  • 12.2. Infectious Diseases
  • 12.3. Musculoskeletal
  • 12.4. Neurology
  • 12.5. Oncology
  • 12.6. Ophthalmology

13. Imaging CRO Market, by End-User

  • 13.1. Biotechnology Firms
  • 13.2. Medical Device Companies
  • 13.3. Pharmaceutical Companies
  • 13.4. Research & Academic Institutions

14. Imaging CRO Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Imaging CRO Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Imaging CRO Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH
    • 17.3.2. Biospective Inc.
    • 17.3.3. Biotrial
    • 17.3.4. Bruker Corporation
    • 17.3.5. Celentyx Ltd.
    • 17.3.6. Charles River Laboratories, Inc.
    • 17.3.7. Clario
    • 17.3.8. EPS Corporation
    • 17.3.9. GVK Biosciences Private Limited
    • 17.3.10. ICON PLC
    • 17.3.11. Image Analysis Group
    • 17.3.12. Intelerad Medical Systems Incorporated
    • 17.3.13. IQVIA Inc.
    • 17.3.14. Median Technologies PLC
    • 17.3.15. Medidata by Dassault Systemes S.E.
    • 17.3.16. MERIT CRO, Inc.
    • 17.3.17. Micron, Inc.
    • 17.3.18. Mint Medical Inc.
    • 17.3.19. MUSASHI IMAGE JOHO CO.,LTD.
    • 17.3.20. Parexel International Corporation
    • 17.3.21. Perceptive Informatics LLC
    • 17.3.22. Visikol, Inc.
    • 17.3.23. WCG Clinical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMAGING CRO MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IMAGING CRO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS IMAGING CRO MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL IMAGING CRO MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL IMAGING CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. IMAGING CRO MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. IMAGING CRO MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMAGING CRO MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMAGING CRO MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMAGING CRO MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMAGING CRO MARKET SIZE, BY FULL-SERVICE CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CORE LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING CROS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMAGING CRO MARKET SIZE, BY CLINICAL IMAGING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMAGING CRO MARKET SIZE, BY DATA MANAGEMENT & INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMAGING CRO MARKET SIZE, BY PROJECT MANAGEMENT & TRIAL SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMAGING CRO MARKET SIZE, BY REGULATORY & COMPLIANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMAGING CRO MARKET SIZE, BY MULTISLICE CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMAGING CRO MARKET SIZE, BY SPIRAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IMAGING CRO MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IMAGING CRO MARKET SIZE, BY FUNCTIONAL MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IMAGING CRO MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IMAGING CRO MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IMAGING CRO MARKET SIZE, BY 3D & 4D ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IMAGING CRO MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE I, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE II, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IMAGING CRO MARKET SIZE, BY PHASE III, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IMAGING CRO MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IMAGING CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IMAGING CRO MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL IMAGING CRO MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL IMAGING CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL IMAGING CRO MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL IMAGING CRO MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL IMAGING CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL IMAGING CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL IMAGING CRO MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL IMAGING CRO MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL IMAGING CRO MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS IMAGING CRO MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS IMAGING CRO MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST IMAGING CRO MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST IMAGING CRO MARKET SIZE, BY PHASE OF CLINICAL TRIALS, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST IMAGING CRO MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST IMAGING CRO MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST IMAGING CRO MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST IMAGING CRO MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA IMAGING CRO MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA IMAGING CRO MARKET SIZE, BY PROVIDER TYPES, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA IMAGING CRO MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA IMAGING CRO MARKET SIZE, BY IMAGING MODALITY, 2025-2032 (USD MILLION)
  • TABLE 333. AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2018-2024 (USD MILLION)
  • TABLE 334. AFRICA IMAGING CRO MARKET SIZE, BY COMPUTER TOMOGRAPHY (CT) SCAN, 2025-2032 (USD MILLION)
  • TABLE 335. AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2018-2024 (USD MILLION)
  • TABLE 336. AFRICA IMAGING CRO MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI), 2025-2032 (USD MILLION)
  • TABLE 337. AFRICA IMAGING CRO MARKET SIZE, BY ULTRASOUND, 20